Natraj Proteins Intrinsic Value
NATRAJPR • FMCG
Current Stock Price
₹34.81
Primary Intrinsic Value
₹40.80
Market Cap
₹13.9 Cr
+100.0%
Upside
Median Value
₹69.62
Value Range
₹22 - ₹87
Assessment
Trading Below Calculated Value
Safety Margin
50.0%
NATRAJPR Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹40.80 | ₹32.64 - ₹48.96 | +17.2% | EPS: ₹3.40, Sector P/E: 12x |
| Book Value Method | asset | ₹80.00 | ₹72.00 - ₹88.00 | +129.8% | Book Value/Share: ₹80.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹69.62 | ₹62.66 - ₹76.58 | +100.0% | Revenue/Share: ₹265.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹60.00 | ₹54.00 - ₹66.00 | +72.4% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹87.03 | ₹69.62 - ₹104.44 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹21.76 | ₹19.58 - ₹23.94 | -37.5% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹27.20 | ₹24.48 - ₹29.92 | -21.9% | Revenue Growth: -7.5%, Adj P/E: 8.0x |
| Graham Defensive Method | conservative | ₹78.23 | ₹70.41 - ₹86.05 | +124.7% | EPS: ₹3.40, BVPS: ₹80.00 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
NATRAJPR Intrinsic Value Analysis
What is the intrinsic value of NATRAJPR?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Natraj Proteins (NATRAJPR) is ₹69.62 (median value). With the current market price of ₹34.81, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹21.76 to ₹87.03, indicating ₹21.76 - ₹87.03.
Is NATRAJPR undervalued or overvalued?
Based on our multi-method analysis, Natraj Proteins (NATRAJPR) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 21.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 3.1% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.80x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Natraj Proteins
Additional stock information and data for NATRAJPR
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹22 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹3 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹6 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹9 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |